Norges Bank Sage Therapeutics, Inc. Transaction History

Norges Bank

$716 Trillion
Q3 2024

48 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$17.1 - $22.26 $5 Million - $6.51 Million	292,294 New	292,294 $6.33 Million
Q3 2023 Nov 13, 2024	BUY	$16.75 - $48.98 $5.47 Million - $16 Million	326,480 New	326,480 $6.72 Million
Q3 2023 Nov 13, 2023	SELL	$16.75 - $48.98 $8.22 Million - $24 Million	-490,702 Closed	0 $0
Q2 2023 Aug 14, 2024	BUY	$40.65 - $59.54 $15.9 Million - $23.3 Million	391,771 New	391,771 $18.4 Million
Q2 2023 Aug 14, 2023	SELL	$40.65 - $59.54 $18.4 Million - $26.9 Million	-452,022 Closed	0 $0
Q1 2023 May 15, 2024	BUY	$37.27 - $46.57 $14.6 Million - $18.2 Million	391,771 New	391,771 $16.4 Million
Q4 2022 Feb 14, 2023	BUY	$32.2 - $43.61 $15.8 Million - $21.4 Million	490,702 New	490,702 $18.7 Million
Q3 2022 Nov 13, 2023	BUY	$32.28 - $43.27 $15.8 Million - $21.2 Million	490,702 New	490,702 $19.2 Million
Q2 2022 Aug 14, 2023	BUY	$27.52 - $37.99 $12.4 Million - $17.2 Million	452,022 New	452,022 $14.6 Million
Q1 2022 May 12, 2023	SELL	$30.71 - $45.71 $904,962 - $1.35 Million	-29,468 Reduced 6.01%	461,234 $15.3 Million
Q1 2022 May 09, 2022	SELL	$30.71 - $45.71 $14.7 Million - $21.9 Million	-478,436 Closed	0 $0
Q4 2021 Mar 09, 2022	BUY	$37.06 - $47.11 $17.7 Million - $22.5 Million	478,436 New	478,436 $20.4 Million
Q3 2021 Nov 14, 2022	BUY	$40.26 - $57.37 $18.9 Million - $26.9 Million	468,981 New	468,981 $20.8 Million
Q3 2021 Nov 05, 2021	SELL	$40.26 - $57.37 $19 Million - $27.1 Million	-472,877 Closed	0 $0
Q2 2021 Aug 15, 2022	BUY	$54.88 - $79.29 $26 Million - $37.5 Million	472,877 New	472,877 $26.9 Million
Q2 2021 Aug 10, 2021	SELL	$54.88 - $79.29 $13.3 Million - $19.2 Million	-242,187 Closed	0 $0
Q1 2021 May 09, 2022	BUY	$70.65 - $96.76 $17.1 Million - $23.4 Million	242,187 New	242,187 $18.1 Million
Q1 2021 May 07, 2021	SELL	$70.65 - $96.76 $36 Million - $49.3 Million	-509,133 Closed	0 $0
Q4 2020 Mar 02, 2021	BUY	$58.41 - $89.06 $29.7 Million - $45.3 Million	509,133 New	509,133 $44 Million
Q4 2020 Feb 10, 2021	SELL	$58.41 - $89.06 $33 Million - $50.4 Million	-565,633 Closed	0 $0
Q3 2020 Nov 12, 2021	BUY	$41.13 - $62.45 $23.3 Million - $35.3 Million	565,633 New	565,633 $34.6 Million
Q3 2020 Nov 10, 2020	SELL	$41.13 - $62.45 $23.6 Million - $35.8 Million	-573,578 Closed	0 $0
Q2 2020 Aug 13, 2021	BUY	$25.95 - $43.15 $14.9 Million - $24.7 Million	573,578 New	573,578 $23.8 Million
Q2 2020 Aug 07, 2020	SELL	$25.95 - $43.15 $13.1 Million - $21.8 Million	-504,231 Closed	0 $0
Q1 2020 May 07, 2021	BUY	$26.15 - $77.24 $13.2 Million - $38.9 Million	504,231 New	504,231 $14.5 Million
Q1 2020 May 08, 2020	SELL	$26.15 - $77.24 $12.7 Million - $37.4 Million	-484,738 Closed	0 $0
Q4 2019 Mar 03, 2020	BUY	$60.18 - $154.77 $29.2 Million - $75 Million	484,738 New	484,738 $35 Million
Q4 2019 Feb 12, 2020	SELL	$60.18 - $154.77 $31.2 Million - $80.3 Million	-519,036 Closed	0 $0
Q3 2019 Nov 13, 2020	BUY	$140.29 - $189.96 $72.8 Million - $98.6 Million	519,036 New	519,036 $72.8 Million
Q3 2019 Nov 08, 2019	SELL	$140.29 - $189.96 $67.1 Million - $90.9 Million	-478,528 Closed	0 $0
Q2 2019 Aug 13, 2020	BUY	$157.85 - $183.09 $75.5 Million - $87.6 Million	478,528 New	478,528 $87.6 Million
Q2 2019 Aug 09, 2019	SELL	$157.85 - $183.09 $64.8 Million - $75.2 Million	-410,737 Closed	0 $0
Q1 2019 May 11, 2020	BUY	$89.33 - $163.65 $5.85 Million - $10.7 Million	65,455 Added 18.96%	410,737 $65.3 Million
Q4 2018 Mar 04, 2019	BUY	$81.94 - $139.71 $28.3 Million - $48.2 Million	345,282 New	345,282 $33.1 Million
Q4 2018 Feb 08, 2019	SELL	$81.94 - $139.71 $27.6 Million - $47 Million	-336,344 Closed	0 $0
Q3 2018 Nov 12, 2019	BUY	$138.11 - $169.04 $46.5 Million - $56.9 Million	336,344 New	336,344 $47.5 Million
Q3 2018 Nov 09, 2018	SELL	$138.11 - $169.04 $39.8 Million - $48.7 Million	-287,840 Closed	0 $0
Q2 2018 Aug 12, 2019	BUY	$140.36 - $175.76 $40.4 Million - $50.6 Million	287,840 New	287,840 $45.1 Million
Q2 2018 Jul 23, 2018	SELL	$140.36 - $175.76 $35.6 Million - $44.6 Million	-253,551 Closed	0 $0
Q1 2018 May 15, 2019	BUY	$152.15 - $192.33 $38.6 Million - $48.8 Million	253,551 New	253,551 $40.8 Million
Q1 2018 May 09, 2018	SELL	$152.15 - $192.33 $38 Million - $48 Million	-249,821 Closed	0 $0
Q4 2017 Mar 05, 2018	BUY	$60.72 - $167.34 $15.2 Million - $41.8 Million	249,821 New	249,821 $41.1 Million
Q4 2017 Feb 09, 2018	SELL	$60.72 - $167.34 $14 Million - $38.5 Million	-229,821 Closed	0 $0
Q3 2017 Nov 13, 2018	BUY	$61.4 - $88.52 $14.1 Million - $20.3 Million	229,821 New	229,821 $14.3 Million
Q3 2017 Nov 07, 2017	SELL	$61.4 - $88.52 $14.1 Million - $20.3 Million	-229,821 Closed	0 $0
Q2 2017 Jul 24, 2018	SELL	N/A	-9,040 Reduced 3.78%	229,821 $18.3 Million
Q1 2017 May 11, 2018	SELL	N/A	-5,000 Reduced 2.05%	238,861 $17 Million
Q3 2016 Nov 13, 2017	BUY	N/A	243,861	243,861 $0

Others Institutions Holding SAGE

# of Institutions

198

Shares Held

46.5M

Call Options Held

402K

Put Options Held

209K

View Full List

About Sage Therapeutics, Inc.

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $323M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

More about SAGE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

News

Stay updated on Norges Bank with notifications on news.

Account